GlobalData on MSN23h
Macau approves IASO Bio’s multiple myeloma therapy
Pharmaceutical Administration Bureau has approved IASO Biotherapeutics’ new drug application (NDA) for equecabtagene ...
Innate Pharma S.A. (NASDAQ:IPHA) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 27, 2025 Innate Pharma S.A. misses on earnings expectations. Reported EPS is $-0.33474 ...
JD Supra22h
FDA Approves Fresenius’s Denosumab Biosimilars
On March 26, 2025, the FDA approved Fresenius Kabi’s denosumab biosimilars, CONEXXENCE® (denosumab-bnht) and BOMYNTRA® (denosumab-bnht), ...
Quantbot Technologies LP Has $389,000 Stake in Amgen Inc. (NASDAQ:AMGN)
Quantbot Technologies LP boosted its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 219.5% during the fourth ...
Intech Investment Management LLC Boosts Stock Position in 2seventy bio, Inc. (NASDAQ:TSVT)
Intech Investment Management LLC raised its position in 2seventy bio, Inc. (NASDAQ:TSVT – Free Report) by 41.1% during the fourth quarter, according to the company in its most recent 13F filing with ...
TipRanks on MSN14h
Innate Pharma’s Earnings Call Highlights Progress and Challenges
Innate Pharma S.A. (($FR:IPH)) has held its Q4 earnings call. Read on for the main highlights of the call. Innate Pharma’s recent earnings call ...
How melanoma and other tumors succeed in hiding and resisting immunotherapy
Cutaneous melanoma, the most aggressive form of skin cancer, is characterized by its accumulation of a large number of ...
Frontiers7h
Allogenic Hematopoietic Cell Transplant in Hematological Malignancies: Controversies and Perspective
The Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), since the experiments in rodents in the 50’s, has become a ...